申请人:Bristol-Myers Squibb Company
公开号:US05141959A1
公开(公告)日:1992-08-25
Compounds of the formula ##STR1## wherein R.sub.1 is CH.dbd.CY--C(CH.sub.3).dbd.CHX wherein X and Y are different and each is of the formula ##STR2## wherein R' and R" independently are H or alkyl of C.sub.1-6 and R.sub.1 includes all possible geometric isomers are demonstrated effective in treating inflammation, both topically and internally. The mechanism appears to be the inhibition of phospholipase A.sub.2 enzymes.
式为##STR1##的化合物,其中R.sub.1为CH.dbd.CY--C(CH.sub.3).dbd.CHX,其中X和Y不同,且每个都为式##STR2##中的R'和R"独立地为H或C.sub.1-6烷基,R.sub.1包括所有可能的几何异构体,在局部和内部治疗炎症方面都表现出有效性。机制似乎是通过抑制磷脂酶A.sub.2酶来实现的。